Bortezomib will enhance the level or effect of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Increased flibanserin adverse results may perhaps take place if coadministered with multiple weak CYP3A4 inhibitors. To cut back the risk of dizziness and lightheadedness, rise up slowly and gradually when rising from a https://davidv344vht8.wikinarration.com/user